NCT06155643NARecruiting

EKO SENSORA: Detecting Clinically Significant Murmurs

Corewell Health South

Start Date

10/26/2023

Completion Date

7/26/2027

Summary

The Eko Artificial Intelligence (AI) has primarily been evaluated in the primary care setting. The digital stethoscope records a phonocardiogram of heart sounds of the patient and uses machine learning artificial intelligence to identify if there are abnormalities present (Eko Health, 2023). The Eko SENSORA will be tested in the emergency department. Chest pain, fatigue, shortness of breath and syncope are all symptoms that could indicate a cardiac dysfunction. The hypothesis is that this device will allow us increased ability to detect valvular heart disease that is clinically significant.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Chief complaint of chest pain, shortness of breath, difficulty breathing, or syncope/near-syncope. * Patients with chief complaint of Weakness would be eligible if over the age of 50 and have a history of at least two of hypertension, BMI\>/= 30, diabetes, hyperlipidemia, atrial fibrillation, heart attack, stroke/Transient ischemic attack, prior cardiac surgery or angiography Exclusion Criteria: * Contact isolation patients * Pediatric patients under the age of 18

Interventions

DEVICE

Eko Sensora

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Heart Murmurs

Locations

Corewell Health Lakeland

Saint Joseph, Michigan 49085

United States